Navigation Links
VNUS Medical Technologies, Inc. Announces Board of Director Resignation

SAN JOSE, Calif., July 11 /PRNewswire-FirstCall/ -- VNUS(R) Medical Technologies, Inc. (Nasdaq: VNUS), a leading provider of medical devices for the minimally invasive treatment of venous reflux disease, announced today the resignation of Kathleen D. LaPorte from the Board of Directors. Ms. LaPorte has served on VNUS' Board of Directors since April 1997 and was a general partner in a venture capital firm that funded the company during its start-up activities. There are no immediate plans for a replacement Director.

"The Board and management of VNUS would like to sincerely thank Kathy for her many contributions, support, and sound advice as a key member of the Board since the company's early days," said Brian Farley, President and CEO. "As one of the earliest venture capital investors, Kathy's departure from the Board is a normal step in the company's corporate governance since its IPO in October 2004. We expect to continue our past practice of looking to replace venture investors with highly qualified medical device industry experts."


Founded in 1995 and headquartered in San Jose, California, VNUS Medical Technologies is a worldwide leader in medical devices for the minimally invasive treatment of venous reflux disease, a progressive condition that causes the varicose veins afflicting 25 million Americans. The pioneering company in the field, VNUS offers the ClosureFAST system, which consists of a proprietary radiofrequency (RF) generator and proprietary disposable endovenous catheters and devices to close diseased veins through the application of temperature-controlled RF energy. VNUS devices have been used in more than 300,000 procedures worldwide. For more information, visit


VNUS has made forward-looking statements in this press release within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. These statements related to Board membership are based on information available to VNUS as of the date of this press release and are based on information available to the company as of the date hereof. VNUS expressly disclaims any intent or obligation to update these forward-looking statements except as required by law.

SOURCE VNUS Medical Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Using Mediasite for Lecture Capture Found to Enhance Student Performance at Penn State Milton S. Hershey Medical Center
2. Bold Evolution Transforms National Jewish Medical and Research Center to National Jewish Health
3. 1,000th Uninsured Virginia Patient Secures Access to Quality Medical Care Through Virginia Cares Uninsured Program (VCUP)
4. Merit Medical Pre-Announces Record Sales and Earnings for the Second Quarter Ended June 30, 2008
5. NOTES research activities increase with grants from Olympus medical Systems totaling $1 million
6. SmoothToe Diabetic Socks Acquired by Lifestyle Medical Group
7. Home Medical Equipment Providers Are Appalled by Dead-Doctor Scam, Strongly Support Anti-Fraud Efforts to Protect Medicare System
8. Global Industry Analysts' Releases a Series of Medical Market Research Reports
9. Greenway Medical Technologies Leads Ambulatory Interoperability Exchange
10. Global Access Project (GAP) Study Examining Patients Access to Cancer Care Featured in the Journal of the American Medical Association (JAMA)
11. Nyer Medical Group, Inc. Announces Sale of Companys Florida Medical-Surgical Division; Pharmacy Division Awarded Two-Year Preferred Supplier Contract
Post Your Comments:
(Date:11/24/2015)... ... November 24, 2015 , ... American Family Care (AFC), the ... of a holiday pop-up clinic located in Metro Atlanta’s North Point Mall. The clinic ... and different way. The location is scheduled to operate through Dec. 24. , Holiday ...
(Date:11/24/2015)... Danbury, CT (PRWEB) , ... November 24, 2015 , ... ... Network (WCHN) today announced an innovative study designed to yield insights into how to ... potential development of biomarkers for pancreatic cancer from small, non-coding RNA molecules (ncRNA), genetic ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... Cleveland University-Kansas City (CU-KC), in Overland Park, Kansas. Benson, a fifth-trimester ... University President Carl S. Cleveland III on October 16. , “Katie is very ...
(Date:11/24/2015)... ... November 24, 2015 , ... American Specialty ... Program have announced their endorsement of the Medical Fitness Network (MFN), a ... proud to have the MFN as one of our endorsed organizations,” said ASH ...
(Date:11/24/2015)... ... ... Dr. Kevin Day, local family chiropractor in Warsaw , is hosting a ... During the Indiana winter months, Vitamin D deficiency can lead to Seasonal Affective Disorder ... help provide the tools needed to combat it this year! , “Stress kills us,” ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... Nov. 24, 2015 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" ... announced today that the first patient has been enrolled ... a treatment for metastatic castration-resistant prostate cancer ("mCRPC"). ... --> the United States ... Phase 1/2 clinical trial, ESSA intends to demonstrate the ...
(Date:11/24/2015)... -- Sectra (STO: SECT B) announces that ... multi-year agreement to deploy Breast Imaging PACS in ... the Breast Center a future-proof platform capable of expanding with ... announces that Breast Center of Acadiana has entered ... PACS in its two freestanding imaging centers. This investment will ...
(Date:11/24/2015)... 2015  Ascendant Solutions, Inc. (Pink Sheets: ASDS ) ... Directors has declared a special 1 percent stock dividend on ... December 14, 2015, to shareholders of record December 7, 2015.  ... shares of common stock. --> ... strong endorsement of our confidence in Ascendant,s growth strategy as ...
Breaking Medicine Technology: